A carregar...
Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome
INTRODUCTION: Treatment of hypercholesterolemia in refractory nephrotic syndrome remains a therapeutic challenge. There is not enough evidence supporting the efficacy of statins, and these drugs can be associated with an increased incidence of adverse effects. Herein we summarize our clinical experi...
Na minha lista:
| Publicado no: | Kidney Int Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7783565/ https://ncbi.nlm.nih.gov/pubmed/33426389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.09.046 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|